Impact of the COVID-19 pandemic on global and local trends in drug supply and utilization

When:  Mar 18, 2021 from 9:00 AM to 10:00 AM (ET)
On March 11, 2020, the World Health Organization (WHO) announced the 2019 novel coronavirus (COVID-19) outbreak as a pandemic. Due to COVID-19, governments implemented interim public health measures to limit the spread of coronavirus disease. Such measures have contributed to a disruption of global supply lines and exposed vulnerabilities in the global pharmaceutical supply chain. This critical supply issue has urged drug manufacturers, regulators, and other healthcare stakeholders to initiate an emergency response to support and secure drug supply to their countries during COVID-19.
This session will cover the impact of the pandemic so far using global data from over 70 countries and look to see different policy options available to formulary managers. This information will be vital as the pandemic prolongs and future drug supply shocks.